Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation

被引：13

作者：

Choudhary, Narendra S. ^{[1
]}

Saigal, Sanjiv ^{[1
]}

机构：

[1] Medanta Medic, Medanta Inst Liver Transplantat & Regenerat Med, Gurugram 122001, India

来源：

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2019年 / 9卷 / 05期

关键词：

liver transplantation; NASH; prevention; metabolic syndrome; recurrence; METABOLIC SYNDROME; DE-NOVO; CARDIOVASCULAR-DISEASE; CRYPTOGENIC CIRRHOSIS; STEATOHEPATITIS; IMMUNOSUPPRESSION; METAANALYSIS; RECIPIENTS; RISK; ASSOCIATION;

D O I：

10.1016/j.jceh.2019.05.004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Post-transplant nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) is common and can be recurrent or de novo. The available data suggest that progression of fibrosis is accelerated in these patients compared to NASH in general population. The long-term data suggest more risk of metabolic syndrome and associated metabolic comorbidities and cardiovascular disease in these patients. The current review focuses on prevalence and prevention/treatment of post-transplant NAFLD or NASH.

引用

页码：619 / 624

页数：6

共 50 条

[1] Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation
Patel, Yuval A.
Berg, Carl L.
Moylan, Cynthia A.
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1406 - 1416
[2] Approach to prevention of non-alcoholic fatty liver disease after liver transplantation
Sharma, Praveen
Arora, Anil
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
[3] Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis
Galvin, Zita
Rajakumar, Ramraj
Chen, Emily
Adeyi, Oyedele
Selzner, Markus
Grant, David
Sapisochin, Gonzalo
Greig, Paul
Cattral, Mark
McGilvray, Ian
Ghanekar, Anand
Selzner, Nazia
Lilly, Les
Patel, Keyur
Bhat, Mamatha
LIVER TRANSPLANTATION, 2019, 25 (01) : 56 - 67
[4] Nonalcoholic Fatty Liver Disease After Liver Transplantation for Cryptogenic Cirrhosis or Nonalcoholic Fatty Liver Disease
Yalamanchili, Kanthi
Saadeh, Sherif
Klintmalm, Goeran B.
Jennings, Linda W.
Davis, Gary L.
LIVER TRANSPLANTATION, 2010, 16 (04) : 431 - 439
[5] Nonalcoholic Fatty Liver Disease and Liver Transplantation
Tuan Pham
Dick, Travis B.
Charlton, Michael R.
CLINICS IN LIVER DISEASE, 2016, 20 (02) : 403 - +
[6] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
Carter, Danielle
Dieterich, Douglas T.
Chang, Charissa
CLINICS IN LIVER DISEASE, 2018, 22 (01) : 213 - +
[7] Nonalcoholic Fatty Liver Disease after Liver Transplant
Shetty, Akshay
Giron, Fanny
Divatia, Mukul K.
Ahmad, Muhammad, I
Kodali, Sudha
Victor, David
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (03) : 428 - 435
[8] NONALCOHOLIC FATTY LIVER DISEASE IS THE MOST RAPIDLY INCREASING INDICATION FOR LIVER TRANSPLANTATION IN THE MODERN WORLD
Iljinsky, I. M.
Tsirulnikova, O. M.
VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2019, 21 (03): : 127 - 140
[9] Liver transplantation for nonalcoholic fatty liver disease: New challenges and new opportunities
Shaker, Mina
Tabbaa, Adam
Albeldawi, Mazen
Alkhouri, Naim
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (18) : 5320 - 5330
[10] Nonalcoholic Fatty Liver Disease
Isaacs, Scott
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) : 149 - 164

← 1 2 3 4 5 →